Walgreens Boots Alliance, Inc. or Mesoblast Limited: Who Manages SG&A Costs Better?

Walgreens Boots Alliance vs. Mesoblast: A Tale of SG&A Management

In the competitive world of business, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Walgreens Boots Alliance, Inc. and Mesoblast Limited, two giants in their respective fields, offer a fascinating study in contrasts. From 2014 to 2024, Walgreens consistently reported SG&A expenses that were over 400 times higher than Mesoblast's, reflecting its vast scale and global operations. However, Mesoblast showed a commendable reduction in SG&A costs by approximately 56% from 2015 to 2024, indicating a strategic tightening of its financial belt. Meanwhile, Walgreens saw a steady increase, peaking in 2024. This data highlights the different financial strategies employed by a healthcare retail giant and a biotechnology firm. As businesses navigate economic challenges, understanding these strategies offers valuable insights into effective cost management.